Comparison of guidelines on rectal cancer: exception proves the rule?

Ruoxu Dou(General Hospital of Guangzhou Military Command), Jianping Wang(Sun Yat-sen University), Yanhong Deng(Sun Yat-sen University), Siqi He(Sun Yat-sen University)
Gastroenterology report
August 1, 2021
10.1093/gastro/goab034
Cited by 17

Related Papers

<i>Fusobacterium nucleatum</i>in colorectal carcinoma tissue and patient prognosis
|Gut|2015|1.1k
Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
|Clinical Cancer Research|2018|456
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer
|JAMA|2018|410
Neoadjuvant Modified FOLFOX6 With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Final Results of the Chinese FOWARC Trial
|Journal of Clinical Oncology|2019|410
Modified FOLFOX6 With or Without Radiation Versus Fluorouracil and Leucovorin With Radiation in Neoadjuvant Treatment of Locally Advanced Rectal Cancer: Initial Results of the Chinese FOWARC Multicenter, Open-Label, Randomized Three-Arm Phase III Trial
|Journal of Clinical Oncology|2016|409